Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity.

Quagliariello V, Vecchione R, Coppola C, Di Cicco C, De Capua A, Piscopo G, Paciello R, Narciso V, Formisano C, Taglialatela-Scafati O, Iaffaioli RV, Botti G, Netti PA, Maurea N.

Nutrients. 2018 Sep 14;10(9). pii: E1304. doi: 10.3390/nu10091304.

2.

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

Riccio G, Antonucci S, Coppola C, D'Avino C, Piscopo G, Fiore D, Maurea C, Russo M, Rea D, Arra C, Condorelli G, Di Lisa F, Tocchetti CG, De Lorenzo C, Maurea N.

Front Physiol. 2018 Feb 6;9:38. doi: 10.3389/fphys.2018.00038. eCollection 2018.

3.

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.

Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N.

Cancer Treat Rev. 2018 Feb;63:135-143. doi: 10.1016/j.ctrv.2017.11.009. Epub 2017 Dec 6. Review.

4.

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.

Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N.

Onco Targets Ther. 2016 Nov 2;9:6785-6794. eCollection 2016.

5.

Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.

Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G.

J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e19-e26. Review.

PMID:
27755239
6.

Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.

Madeddu C, Deidda M, Piras A, Cadeddu C, Demurtas L, Puzzoni M, Piscopo G, Scartozzi M, Mercuro G.

J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e12-e18. Review.

PMID:
27755238
7.

Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.

Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, Esposito E, De Lorenzo C, De Laurentiis M, Spallarossa P, Mercuro G.

J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S19-26. doi: 10.2459/JCM.0000000000000377. Review.

PMID:
27183521
8.

Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.

Madeddu C, Deidda M, Piras A, Cadeddu C, Demurtas L, Puzzoni M, Piscopo G, Scartozzi M, Mercuro G.

J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S12-8. doi: 10.2459/JCM.0000000000000376. Review.

PMID:
27183520
9.

WITHDRAWN:A Practical Approach for Management of QT Prolongation Induced by Anticancer Drugs.

Maurea N, Coppola C, Piscopo G, Galletta F, Riccio G, De Lorenzo C.

Oncologist. 2016 Mar 14. pii: theoncologist.2015-0313. [Epub ahead of print] Review.

10.

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?

Riccio G, Coppola C, Piscopo G, Capasso I, Maurea C, Esposito E, De Lorenzo C, Maurea N.

Hum Vaccin Immunother. 2016 May 3;12(5):1124-31. doi: 10.1080/21645515.2015.1125056. Epub 2016 Feb 2.

11.

Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.

Tocchetti CG, Carpi A, Coppola C, Quintavalle C, Rea D, Campesan M, Arcari A, Piscopo G, Cipresso C, Monti MG, De Lorenzo C, Arra C, Condorelli G, Di Lisa F, Maurea N.

Eur J Heart Fail. 2014 Apr;16(4):358-66.

12.

The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors.

Tocchetti CG, Gallucci G, Coppola C, Piscopo G, Cipresso C, Maurea C, Giudice A, Iaffaioli RV, Arra C, Maurea N.

Eur J Heart Fail. 2013 May;15(5):482-9. doi: 10.1093/eurjhf/hft008. Epub 2013 Jan 16. Review.

13.

Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge.

Tocchetti CG, Ragone G, Coppola C, Rea D, Piscopo G, Scala S, De Lorenzo C, Iaffaioli RV, Arra C, Maurea N.

Eur J Heart Fail. 2012 Feb;14(2):130-7. doi: 10.1093/eurjhf/hfr165. Epub 2012 Jan 4. Review.

14.

Altered signaling through IL-12 receptor in children with very high serum IgE levels.

Fusco A, Vigliano I, Palamaro L, Cirillo E, Aloj G, Piscopo G, Giardino G, Pignata C.

Cell Immunol. 2010;265(1):74-9. doi: 10.1016/j.cellimm.2010.07.005. Epub 2010 Jul 21.

PMID:
20696422

Supplemental Content

Loading ...
Support Center